Publication sets guidelines across cancer therapies: Ensuring the best in patient ... ( Reston Va. Now for the first time ex...)

Publication sets guidelines across cancer therapies: Ensuring the best in patient management

Date:4/30/2009

Reston, Va. Now, for the first time, experts have compiled a comprehensive overview of the literature regarding the usefulness of PET imaging for the treatment of several cancers.

Personalizing Cancer Therapy with FDG PET: From RECIST to PERCISTa compilation of results of therapeutic regimens across a broad range of cancers published as a supplement to the Journal of Nuclear Medicineis a unique reference tool presenting the most up-to-date information about the use of fluorodeoxyglucose and positron emission tomography (FDG PET) for monitoring therapy and treatment of many different cancers. Internationally recognized PET imaging specialists and oncologists contributed to and developed this new supplement.

FDG PET is a noninvasive, painless molecular imaging technology that allows physicians to determine how organs and tissues inside the body are functioning on a molecular and cellular level. In the past, collecting information about tumor response in a structured and meaningful format was difficult. As a result, generally accepted criteria for response assessment in solid tumors did not exist. Because each patient is unique, oncologists have no way of accurately predicting which patient will benefit from a specific therapy.

Those involved in the production of the new supplement believe that the international guidelines and criteria for response assessment using PET in solid tumors provided by the new periodical may notably alter cancer treatment and prognosis.

"The literature in this publication suggests that FDG PET could play a significant role in personalizing the treatment of malignant tumors," said Wolfgang Weber, M.D., editor of the supplement and medical director with the division of nuclear medicine at the Albert-Ludwigs University in Freiburg, Germany. "It could positively impact patient care by providing access to critical imaging procedures to ensure that patients get the right treatment early on in their
'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

3

GOOD

Page: 1 2
Related biology news :

1. American Physical Society announces Physics, a new, free, online publication
2. New publication addresses safety of imported foods
3. Not just for the monkeys: New publication shows evolution is everywhere
4. Publication offers labs consensus recommendations for diagnosing parasitic diseases
5. Computer-based tool aids research, helps thwart questionable publication practices
6. Oncolytics Biotech, Inc. announces publication of research
7. Molecular Biology of the Cell celebrates 25 years of publication
8. The International Society for Stem Cell Research releases new guidelines
9. Guidelines urge physical activity during pregnancy
10. Study finds ATV guidelines inadequate
11. New guidelines for treating rheumatoid arthritis

Post Your Comments:

(Date:5/17/2013)... An international team of scientists using a new X-ray ... a living frog embryo in greater detail than ever ... biological research and the search for new treatments for ... Institut fr Technologie in Germany, in collaboration with the ... Argonne National Laboratory, released the most precise depiction ever ...

(Date:5/16/2013)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for The Society for Developmental Biology (SDB) ... 16-20, 2013. These awards are meant to promote ... underrepresented groups into the mainstream of the basic ... young scientists at the SDB 2013 Annual Meeting. ...

(Date:5/16/2013)... shown a gene involved in neurodegenerative disease also plays ... circadian clock. , In a study of the ... Ataxin-2, keeps the clock responsible for sleeping and waking ... of the fruit fly,s sleep-wake cycle is disturbed, making ... fly. , The discovery is particularly interesting because ...

Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2 Gene involved in neurodegeneration keeps clock running 2

[0] New X-ray method shows how frog embryos could help thwart disease [0] MARC Travel Awards announced for the SDB 2013 72nd Annual Meeting [0] Gene involved in neurodegeneration keeps clock running

... that allergic infants may be at increased risk of peanut ... are reported in the November 1 issue of the ... Scott H. Sicherer, MD, Professor of Pediatrics, Jaffe Food Allergy ... U.S. study sites evaluated 503 infants aged three to 15 ...

... MADISON -- They are the portals to the cell, ... living cells and their environments. But these gateways -- ... outside the cell to its vital inner workings remain, ... their structures and how they work. They are of intense ...

... have shown how a protein called perforin punches holes in, ... the mechanism of this assassin is published today in the ... of cleansing and death," says project leader Prof James Whisstock ... been hijacked by viruses or turned into cancer cells and ...

Cached Biology News:Pregnant women who eat peanuts may put infants at increased risk for peanut allergy 2 Chemists concoct new agents to easily study critical cell proteins 2 How do we kill rogue cells? 2

Pregnant women who eat peanuts may put infants at increased risk for peanut allergy Chemists concoct new agents to easily study critical cell proteins How do we kill rogue cells?

(Date:5/16/2013)... Vernon Hills, Ill. (PRWEB) May 16, 2013 ... including benchtop and portable models, from Cole-Parmer is ... professionals. The enhanced line includes: , The new ... that are true workhorses in the lab. They ... superior serum and plasma specimen separation. Their standard ...

(Date:5/16/2013)... May 16, 2013 The registration deadline has been ... Officers (ABFO) 2013 National Conference, the premier conference for ... 28-31 at the Hilton San Diego Bayfront. ... year,s conference and want to make sure as many ... Brandi Roberts , Chief Financial Officer ...

(Date:5/16/2013)... YORK , May 16, 2013 ... new market research report is available ... Competitor Analysis: Therapeutic ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ... The new ...

(Date:5/16/2013)... Dr. Stephen Y. Chou, Founder of Nanonex ... and Applications” at IEEE Nano 2013 in Beijing, China, ... by Chou, is becoming one of the most critical ... sub-10 nm resolution, large area, and low cost unmatchable ... and manufacturing in a broad range of industries, from ...

Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2 Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2 Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3 Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8 Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2

[0] Cole-Parmer Offers Enhanced Selection of Centrifuges [0] Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego [0] Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors [0] Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013

... In the news release, "Health Robotics Reports Record-Breaking Revenues,EBITDA, Net Profits, and Cash-Flow for its Fiscal Year 2009" ... the company that "EUR VAR" has been changed to "$ VAR" in,the third column header of both tables. Complete, corrected release follows: ... ... , ...

... , GREAT RIVER, N.Y. , March 15 ... enterprise-wide software and services for health and human services ... the next generation of the company,s industry leading electronic ... My Avatar software is being demonstrated at the National ...

... ... ... - Interaction of nimotuzumab with EGFRvIII, ... , , ...

/C O R R E C T I O N -- Health Robotics/Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations

Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...

Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...

HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....

Human CXCL14/BRAK Affinity Purified Polyclonal Ab...

Biology Products:

Goat Anti-Human RELT / TNFRSF19L Polyclonal Antibody, Unconjugated from R&D Systems Goat Anti-Mouse NOV / CCN3 Polyclonal Antibody, Unconjugated from R&D Systems HiTrap NHS-activated HP from GE Healthcare, formerly Amersham Biosciences Goat Anti-Human CXCL14 / BRAK Polyclonal Antibody, Unconjugated from R&D Systems